Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
about
Interventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentInterventions for preventing oral mucositis for patients with cancer receiving treatmentProtection against Radiotherapy-Induced ToxicityOral and dental considerations in pediatric leukemic patientPre-treatment with amifostine protects against cyclophosphamide-induced disruption of taste in miceEffect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsChemotherapy- and radiotherapy-induced oral mucositis: review of preventive strategies and treatment.Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs)Early biomarker for radiation-induced wounds: day one post-irradiation assessment using hemoglobin concentration measured from diffuse optical reflectance spectroscopy.Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Evaluation of the efficacy of radiation-modifying compounds using γH2AX as a molecular marker of DNA double-strand breaksShould supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Prevention and treatment of the consequences of head and neck radiotherapy.Head and neck squamous cell carcinoma: optimizing the therapeutic index.Gastrointestinal radiation injury: prevention and treatment.Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study.Do antioxidants interfere with radiation therapy for cancer?Late oral complications following radiotherapy for head and neck cancers.Amifostine protects vascularity and improves union in a model of irradiated mandibular fracture healing.Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases.Evaluation of current and upcoming therapies in oral mucositis prevention.Salivary gland sparing in the treatment of head and neck cancer.The effect of amifostine on submandibular gland histology after radiation.Systematic review of amifostine for the management of oral mucositis in cancer patients.Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.Oral Mucositis: understanding the pathology and managementSurvey of Policies and Guidelines on Antioxidant Use for Cancer Prevention, Treatment, and Survivorship in North American Cancer Centers: What Do Institutions Perceive as Evidence?Preparation of amifostine polylactide-co-glycolide microspheres and its irradiation protective to mouse through oral administration.Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.Radioprotection With Amifostine Enhances Bone Strength and Regeneration and Bony Union in a Rat Model of Mandibular Distraction Osteogenesis.Effects of dexpanthenol with or without Aloe vera extract on radiation-induced oral mucositis: preclinical studies.Cytogenetic damage induced by radiotherapy. Evaluation of protection by amifostine and analysis of chromosome aberrations persistence.Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.Phase I clinical trial of concurrent paclitaxel, carboplatin, and external beam chest irradiation with glutamine in patients with locally advanced non-small cell lung cancer.Plastische Rekonstruktion von StrahlenfolgenPlastische Rekonstruktion von Strahlenfolgen
P2860
Q24235217-D72990D0-59F8-41F2-8DDB-11D7C99F682AQ24235482-1273966A-CE8A-4EA1-9D13-787FCCCCCAC6Q24243046-488F4D08-3076-47F7-92DE-D6BE4CE8AF46Q26741273-9160AB96-3728-4ED4-9827-7CD17D9B892AQ27000488-91510B00-9B17-48D6-A4A6-341758C02127Q28486646-AFDA399F-A528-4208-8365-61E0CF806E31Q28538411-2A581A98-7D78-4142-BA7D-0B42D35BF618Q33217865-139C2FFB-50A9-4B8E-85AD-384A2E0B6CE7Q33399402-9DDC0943-2DE1-47B3-A227-9398CF4784BAQ33683487-AB7F8518-EFC2-4C7A-BAFC-28BEB35CA905Q33824807-5EDB558F-4858-4B63-A12D-57F705470DE7Q34157162-E95A9B78-D199-40DF-921A-6CB7A299D64CQ34299445-89869BDC-841A-4361-B5CC-22851D418CE4Q34567095-8DA0C908-F518-4D33-95AF-23F890F268E8Q34782021-B487453E-2BB2-4E96-8C79-2B251B3202C4Q35150821-952AE0F1-C941-4105-A807-188E5DC5DB1FQ36185629-FA8BD13A-BA2A-4B29-BF08-C577A6E605A4Q36541213-ACDBC1FF-1B54-4562-AAFE-C1D742A508D9Q36544184-CB00F42C-1860-4658-A4A7-9FE48B57FFCCQ36891296-80682E4E-E954-4245-BFAF-0D0286D8FE49Q36924702-656190CA-738D-4A5C-B8B4-DA338D41759FQ36950474-7464110E-040F-40C6-84A6-6CE455DF2C6FQ37378457-C9AF9599-72AC-4A72-9DE5-8872BDBDFDF6Q37699777-2F824845-506A-41D0-85FD-2AF2877622D2Q37818225-3FC26AC4-C273-492D-9435-BF63BAC2454AQ37934975-89AFF346-39CE-4647-AFE2-F02E052E74F1Q38030528-C8C2CDB1-C87A-42F7-AE38-76DAACBEDA58Q38050986-75ACC775-7C6C-4FD5-9BA1-8F599D4798BBQ38651513-16E44A15-7F85-48E9-9CCF-BE92F0015563Q42547372-282FD47B-7E70-48DA-97E7-84DE1360E873Q43429878-25A00DB3-3174-4031-BB2E-B09F22E04085Q44365761-424DE5D6-E61A-40AF-BAF3-D8674EC58020Q44620265-AE3B2804-CF3A-40E0-BE14-4232568BD803Q44918838-E6E6BACE-7FDD-4A1B-A6A3-E63AE629B607Q46601069-532B3619-C85F-46BD-941E-B94554F41034Q46733588-FD8883B0-89E0-4D9C-B226-7009D6036093Q53226224-CA14D0C2-0322-49D6-AA01-2C5CAA500AA8Q53537530-23A412AF-D6B8-4FDC-B182-7015A71F311DQ57530884-28A6DBB0-F081-4951-92B0-966D4BFF802BQ57530894-830C541C-F541-4F26-9443-596F9E04A781
P2860
Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@en
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@nl
type
label
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@en
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@nl
prefLabel
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@en
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@nl
P2093
P1476
Prophylactic use of amifostine ...... tomia in head-and-neck cancer.
@en
P2093
Dosia Antonadou
Maria Puglisi
Maria Synodinou
Marizenia Pepelassi
Nicolas Throuvalas
P304
P356
10.1016/S0360-3016(01)02683-9
P407
P577
2002-03-01T00:00:00Z